Nippon Shinyaku Co., Ltd. (4516.T)

JPY 3622.0

(1.54%)

Long Term Debt Summary of Nippon Shinyaku Co., Ltd.

  • Nippon Shinyaku Co., Ltd.'s latest annual long term debt in 2023 was 1.15 Billion JPY , up 0.35% from previous year.
  • Nippon Shinyaku Co., Ltd.'s latest quarterly long term debt in 2024 Q1 was - JPY , down 0.0% from previous quarter.
  • Nippon Shinyaku Co., Ltd. reported annual long term debt of 1.14 Billion JPY in 2022, down -5.82% from previous year.
  • Nippon Shinyaku Co., Ltd. reported annual long term debt of 1.21 Billion JPY in 2021, down -11.86% from previous year.
  • Nippon Shinyaku Co., Ltd. reported quarterly long term debt of 971 Million JPY for 2023 Q1, down -15.42% from previous quarter.
  • Nippon Shinyaku Co., Ltd. reported quarterly long term debt of 1.15 Billion JPY for 2023 Q4, up 53.4% from previous quarter.

Annual Long Term Debt Chart of Nippon Shinyaku Co., Ltd. (2023 - 2004)

Historical Annual Long Term Debt of Nippon Shinyaku Co., Ltd. (2023 - 2004)

Year Long Term Debt Long Term Debt Growth
2023 1.15 Billion JPY 0.35%
2022 1.14 Billion JPY -5.82%
2021 1.21 Billion JPY -11.86%
2020 1.38 Billion JPY 59.7%
2019 866 Million JPY 0.0%
2018 - JPY 0.0%
2017 - JPY 0.0%
2016 - JPY 0.0%
2015 - JPY 0.0%
2014 - JPY 0.0%
2013 - JPY 0.0%
2012 - JPY 0.0%
2011 - JPY 0.0%
2010 - JPY 0.0%
2009 - JPY -100.0%
2008 182 Million JPY 208.47%
2007 59 Million JPY -95.18%
2006 1.22 Billion JPY -49.5%
2005 2.42 Billion JPY -33.95%
2004 3.67 Billion JPY 0.0%

Peer Long Term Debt Comparison of Nippon Shinyaku Co., Ltd.

Name Long Term Debt Long Term Debt Difference
Pharma Foods International Co., Ltd. 1.23 Billion JPY 6.418%
Takeda Pharmaceutical Company Limited 4476.5 Billion JPY 99.974%
Sumitomo Pharma Co., Ltd. 133.36 Billion JPY 99.136%
Shionogi & Co., Ltd. 8.75 Billion JPY 86.839%
Wakamoto Pharmaceutical Co.,Ltd. - JPY -Infinity%
Kaken Pharmaceutical Co., Ltd. - JPY -Infinity%
Eisai Co., Ltd. 134.77 Billion JPY 99.145%
Morishita Jintan Co., Ltd. 106 Million JPY -986.792%
Hisamitsu Pharmaceutical Co., Inc. 76 Million JPY -1415.789%
Mochida Pharmaceutical Co., Ltd. - JPY -Infinity%
Fuso Pharmaceutical Industries,Ltd. 7.02 Billion JPY 83.592%
Nippon Chemiphar Co., Ltd. 13.34 Billion JPY 91.367%
Tsumura & Co. 54.37 Billion JPY 97.881%
Kissei Pharmaceutical Co., Ltd. - JPY -Infinity%
Torii Pharmaceutical Co., Ltd. 22 Million JPY -5136.364%
Towa Pharmaceutical Co., Ltd. 189.12 Billion JPY 99.391%
Fuji Pharma Co., Ltd. 11.92 Billion JPY 90.339%
Zeria Pharmaceutical Co., Ltd. 7.94 Billion JPY 85.498%
KYORIN Holdings, Inc. 435 Million JPY -164.828%
Taiko Pharmaceutical Co.,Ltd. 2.74 Billion JPY 57.972%
Daito Pharmaceutical Co.,Ltd. 4.66 Billion JPY 75.327%
SymBio Pharmaceuticals Limited - JPY -Infinity%
MedRx Co., Ltd - JPY -Infinity%
Mizuho Medy Co.,Ltd. - JPY -Infinity%
Solasia Pharma K.K. 27 Million JPY -4166.667%
Modalis Therapeutics Corporation 412.5 Million JPY -179.273%
ASKA Pharmaceutical Holdings Co.,Ltd. 4.5 Billion JPY 74.428%
Sawai Group Holdings Co., Ltd. 66.84 Billion JPY 98.277%
Cyfuse Biomedical K.K. 345 Million JPY -233.913%
Toho Holdings Co., Ltd. 28.16 Billion JPY 95.91%
Koa Shoji Holdings Co.,Ltd. 1.59 Billion JPY 27.61%